Flarin is a startup based in the United Kingdom, most recent round Series-c-plus, 1 tracked investor.
Flarin is a company headquartered in the United Kingdom. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Flarin is a pharmaceutical company that produces a patented lipid-formulated ibuprofen product designed to provide effective relief from joint, muscular, and arthritic pain. The formulation allows for better absorption and stomach protection compared to standard ibuprofen.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.